Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia
Articolo
Data di Pubblicazione:
2000
Citazione:
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia / Bernardi, F., Lanzone, A., Cento, R.M., Spada, R.S., Pezzani, I., Genazzani, A., Luisi, S., Luisi, M., Petraglia, F., Genazzani, A.R.. - In: EUROPEAN JOURNAL OF ENDOCRINOLOGY. - ISSN 0804-4643. - STAMPA. - 142:5(2000), pp. 466-471. [10.1530/eje.0.1420466]
Abstract:
Neurosteroids have been suggested to be involved in the regulation of cognitive performances. A major neurosteroid gamma-aminobutyric acid (GABA) agonist is allopregnanolone: the main source of circulating allopregnanolone is the adrenal cortex. Studies indicated that a disturbance of the central regulation of the hypothalamic-pituitary-adrenocortical axis occurs in both senile (Alzheimer's disease: AD) and vascular dementia (VD).
Tipologia CRIS:
Articolo su rivista
Keywords:
Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Case-Control Studies; Corticotropin-Releasing Hormone; Dehydroepiandrosterone; Dementia, Vascular; Female; GABA Modulators; Humans; Hydrocortisone; Male; Middle Aged; Pregnanolone
Elenco autori:
Bernardi, F; Lanzone, A; Cento, R. M; Spada, R. S; Pezzani, I; Genazzani, Alessandro; Luisi, S; Luisi, M; Petraglia, F; Genazzani, A. R.
Link alla scheda completa:
Pubblicato in: